Displaying drugs 2576 - 2600 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Phenylalanine | 165.1891 C9H11NO2 |  | An amino acid commonly found as a component of total parenteral nutrition. | Amino Acids, Aromatic / Amino Acids, Essential |
| Tyrosine | 181.1885 C9H11NO3 |  | An amino acid commonly found as a component in total parenteral nutrition. | Amino Acids, Aromatic |
| Levodopa | 197.1879 C9H11NO4 |  | A dopamine precursor used in the management of Parkinson's disease, often in combination with carbidopa, as well as other conditions associated with parkinsonism. | Dopa and Dopa Derivatives |
| Droxidopa | 213.189 C9H11NO5 |  | A medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease. | Adrenergic and Dopaminergic Agents |
| Moxonidine | 241.677 C9H12ClN5O |  | An imidazoline/α-2 receptor agonist used to treat hypertension, especially in cases where ACE inhibitors, β-blockers, calcium channel blockers, and thiazides are not appropriate or provide inadequate blood pressure control. | Imidazoline Receptor Agonists |
| Protionamide | 180.27 C9H12N2S |  | An antitubercular thioamide-derivative used in the treatment of multi-drug resistant (MDR) tuberculosis and leprosy. | Thiocarbamide Derivatives |
| Foslevodopa | 277.169 C9H12NO7P |  | Foslevodopa is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced... | Dopa and Dopa Derivatives |
| Dextroamphetamine | 135.2062 C9H13N |  | A sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. | Centrally Acting Sympathomimetics |
| Amphetamine | 135.2062 C9H13N |  | A CNS stimulant and sympathomimetic agent indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). | Centrally Acting Sympathomimetics |
| Pyridostigmine | 181.2117 C9H13N2O2 |  | A cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants. | Cholinesterase Inhibitors / Pyridinium Compounds |
| Zalcitabine | 211.2178 C9H13N3O3 |  | A dideoxynucleoside used to treat HIV. | Nucleoside and Nucleotide Reverse Transcriptase Inhibitors |
| Cytarabine | 243.2166 C9H13N3O5 |  | A pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. | Pyrimidine Analogues |
| Ganciclovir | 255.2306 C9H13N5O4 |  | A DNA polymerase inhibitor used to treat cytomegalovirus and herpetic keratitis of the eye. | Antiviral Agents / Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Phenylpropanolamine | 151.209 C9H13NO |  | A sympathomimetic that was previously used in nasal decongestants and weight loss products, but has been withdrawn by the FDA due to safety risks and lack of efficacy. | Sympathomimetics |
| Hydroxyamphetamine | 151.2056 C9H13NO |  | An indirectly acting sympathomimetic agent producing mydriasis for diagnostic purposes. | Adrenergic Agonists / Amphetamines / Mydriatics / Sympathomimetics |
| Ethinamate | 167.205 C9H13NO2 |  | Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents. | Acids, Acyclic |
| Metaraminol | 167.205 C9H13NO2 |  | For the treatment and prevention of hypotension due to hemorrhage, spinal anesthesia, and shock associated with brain damage | Adrenergic and Dopaminergic Agents |
| Phenylephrine | 167.205 C9H13NO2 |  | An alpha-1 adrenergic agonist used in the management of hypotension, generally in the surgical setting associated with the use of anesthetics. | Adrenergic and Dopaminergic Agents / Sympathomimetics / Sympathomimetics Excl. Antiglaucoma Preparations / Sympathomimetics Used as Decongestants / Sympathomimetics, Plain |
| Levonordefrin | 183.2044 C9H13NO3 |  | A topical sympathomimetic amine found in local anesthetic products that is used for nasal decongestion or vasoconstriction during dental procedures. | Agents producing tachycardia / Agents that produce hypertension |
| Epinephrine | 183.2044 C9H13NO3 |  | A hormone and neurotransmitter used to treat allergic reactions, to restore cardiac rhythm, and to control mucosal congestion, glaucoma, and asthma. | Adrenergic and Dopaminergic Agents / Local Hemostatics / Sympathomimetics in Glaucoma Therapy / Sympathomimetics, Plain |
| Cedazuridine | 268.217 C9H14F2N2O5 |  | A cytidine deaminase inhibitor coadministered with the hypomethylating agent decitabine for the treatment of variable forms of myelodysplastic syndrome (MDS). | Cytidine Deaminase, antagonists & inhibitors / Nucleic Acids, Nucleotides, and Nucleosides / Nucleosides / Pyrimidine Nucleosides / Pyrimidines / Ribonucleosides |
| Molsidomine | 242.235 C9H14N4O4 |  | A long-acting vasodilator used to treat angina pectoris, including in association with left heart failure and acute myocardial infarction. | Morpholines / Nitric Oxide Donors / Sydnones / Vasodilating Agents |
| Minoxidil | 209.2483 C9H15N5O |  | An antihypertensive vasodilating agent used for resistant hypertension that is symptomatic or has caused end organ damage. | Pyrimidine Derivatives |
| Sapropterin | 241.2471 C9H15N5O3 |  | A cofactor used as an adjunct to phenylalanine restriction in the treatment of phenylketonuria (PKU). | Various Alimentary Tract and Metabolism Products |
| Aceclidine | 169.224 C9H15NO2 |  | Aceclidine has been marketed in Europe but has not been used clinically in the United States. It is used in the treatment of open-angle glaucoma and is a parasympathomimetic agent. | Parasympathomimetics |
Displaying drugs 2576 - 2600 of 2785 in total